Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AID3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 179 | 183 | PF00656 | 0.539 |
CLV_C14_Caspase3-7 | 272 | 276 | PF00656 | 0.441 |
CLV_NRD_NRD_1 | 31 | 33 | PF00675 | 0.507 |
CLV_PCSK_KEX2_1 | 266 | 268 | PF00082 | 0.526 |
CLV_PCSK_KEX2_1 | 31 | 33 | PF00082 | 0.532 |
CLV_PCSK_KEX2_1 | 82 | 84 | PF00082 | 0.453 |
CLV_PCSK_PC1ET2_1 | 266 | 268 | PF00082 | 0.526 |
CLV_PCSK_PC1ET2_1 | 82 | 84 | PF00082 | 0.525 |
CLV_PCSK_SKI1_1 | 196 | 200 | PF00082 | 0.373 |
CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.558 |
DOC_CYCLIN_RxL_1 | 111 | 123 | PF00134 | 0.409 |
DOC_CYCLIN_RxL_1 | 193 | 201 | PF00134 | 0.476 |
DOC_CYCLIN_yCln2_LP_2 | 321 | 327 | PF00134 | 0.614 |
DOC_PP1_RVXF_1 | 139 | 145 | PF00149 | 0.495 |
DOC_PP1_RVXF_1 | 194 | 200 | PF00149 | 0.469 |
DOC_USP7_MATH_1 | 122 | 126 | PF00917 | 0.545 |
DOC_USP7_MATH_1 | 44 | 48 | PF00917 | 0.570 |
DOC_USP7_MATH_2 | 121 | 127 | PF00917 | 0.423 |
DOC_USP7_UBL2_3 | 252 | 256 | PF12436 | 0.261 |
DOC_WW_Pin1_4 | 157 | 162 | PF00397 | 0.404 |
DOC_WW_Pin1_4 | 215 | 220 | PF00397 | 0.610 |
DOC_WW_Pin1_4 | 7 | 12 | PF00397 | 0.676 |
LIG_14-3-3_CanoR_1 | 196 | 206 | PF00244 | 0.456 |
LIG_14-3-3_CanoR_1 | 267 | 273 | PF00244 | 0.509 |
LIG_14-3-3_CanoR_1 | 308 | 317 | PF00244 | 0.381 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.484 |
LIG_deltaCOP1_diTrp_1 | 100 | 109 | PF00928 | 0.328 |
LIG_FHA_1 | 125 | 131 | PF00498 | 0.433 |
LIG_FHA_1 | 216 | 222 | PF00498 | 0.611 |
LIG_FHA_1 | 236 | 242 | PF00498 | 0.245 |
LIG_FHA_1 | 277 | 283 | PF00498 | 0.401 |
LIG_FHA_1 | 309 | 315 | PF00498 | 0.321 |
LIG_FHA_2 | 167 | 173 | PF00498 | 0.449 |
LIG_FHA_2 | 177 | 183 | PF00498 | 0.590 |
LIG_FHA_2 | 270 | 276 | PF00498 | 0.447 |
LIG_LIR_Gen_1 | 286 | 295 | PF02991 | 0.388 |
LIG_LIR_Gen_1 | 299 | 309 | PF02991 | 0.291 |
LIG_LIR_Gen_1 | 49 | 60 | PF02991 | 0.476 |
LIG_LIR_Nem_3 | 286 | 290 | PF02991 | 0.410 |
LIG_LIR_Nem_3 | 299 | 305 | PF02991 | 0.303 |
LIG_LIR_Nem_3 | 49 | 55 | PF02991 | 0.477 |
LIG_Pex14_2 | 109 | 113 | PF04695 | 0.396 |
LIG_Pex14_2 | 144 | 148 | PF04695 | 0.397 |
LIG_SH2_CRK | 287 | 291 | PF00017 | 0.315 |
LIG_SH2_SRC | 328 | 331 | PF00017 | 0.583 |
LIG_SH2_STAT5 | 155 | 158 | PF00017 | 0.330 |
LIG_SH2_STAT5 | 192 | 195 | PF00017 | 0.487 |
LIG_SH3_1 | 21 | 27 | PF00018 | 0.616 |
LIG_SH3_3 | 21 | 27 | PF00018 | 0.463 |
LIG_SH3_3 | 225 | 231 | PF00018 | 0.578 |
LIG_SH3_3 | 252 | 258 | PF00018 | 0.353 |
LIG_SH3_3 | 6 | 12 | PF00018 | 0.615 |
LIG_Sin3_3 | 52 | 59 | PF02671 | 0.519 |
LIG_SUMO_SIM_par_1 | 123 | 131 | PF11976 | 0.502 |
LIG_TRAF2_1 | 121 | 124 | PF00917 | 0.664 |
MOD_CK1_1 | 176 | 182 | PF00069 | 0.504 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.664 |
MOD_CK1_1 | 269 | 275 | PF00069 | 0.652 |
MOD_CK1_1 | 72 | 78 | PF00069 | 0.621 |
MOD_CK2_1 | 166 | 172 | PF00069 | 0.596 |
MOD_CK2_1 | 75 | 81 | PF00069 | 0.715 |
MOD_CMANNOS | 307 | 310 | PF00535 | 0.400 |
MOD_GlcNHglycan | 137 | 140 | PF01048 | 0.513 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.709 |
MOD_GlcNHglycan | 182 | 185 | PF01048 | 0.649 |
MOD_GlcNHglycan | 225 | 228 | PF01048 | 0.469 |
MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.767 |
MOD_GSK3_1 | 124 | 131 | PF00069 | 0.536 |
MOD_GSK3_1 | 143 | 150 | PF00069 | 0.303 |
MOD_GSK3_1 | 173 | 180 | PF00069 | 0.578 |
MOD_GSK3_1 | 197 | 204 | PF00069 | 0.372 |
MOD_GSK3_1 | 235 | 242 | PF00069 | 0.484 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.687 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.737 |
MOD_N-GLC_1 | 177 | 182 | PF02516 | 0.484 |
MOD_N-GLC_1 | 44 | 49 | PF02516 | 0.375 |
MOD_NEK2_1 | 135 | 140 | PF00069 | 0.417 |
MOD_NEK2_1 | 147 | 152 | PF00069 | 0.284 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.673 |
MOD_OFUCOSY | 152 | 159 | PF10250 | 0.405 |
MOD_PIKK_1 | 308 | 314 | PF00454 | 0.278 |
MOD_PKA_1 | 266 | 272 | PF00069 | 0.452 |
MOD_PKA_2 | 266 | 272 | PF00069 | 0.565 |
MOD_PKA_2 | 69 | 75 | PF00069 | 0.483 |
MOD_Plk_1 | 123 | 129 | PF00069 | 0.469 |
MOD_Plk_1 | 269 | 275 | PF00069 | 0.450 |
MOD_Plk_1 | 44 | 50 | PF00069 | 0.373 |
MOD_Plk_4 | 124 | 130 | PF00069 | 0.456 |
MOD_Plk_4 | 143 | 149 | PF00069 | 0.331 |
MOD_Plk_4 | 201 | 207 | PF00069 | 0.344 |
MOD_Plk_4 | 240 | 246 | PF00069 | 0.418 |
MOD_ProDKin_1 | 157 | 163 | PF00069 | 0.408 |
MOD_ProDKin_1 | 215 | 221 | PF00069 | 0.601 |
MOD_ProDKin_1 | 7 | 13 | PF00069 | 0.677 |
TRG_ENDOCYTIC_2 | 287 | 290 | PF00928 | 0.292 |
TRG_ER_diArg_1 | 30 | 32 | PF00400 | 0.442 |
TRG_NES_CRM1_1 | 108 | 123 | PF08389 | 0.553 |
TRG_NES_CRM1_1 | 46 | 61 | PF08389 | 0.422 |
TRG_Pf-PMV_PEXEL_1 | 196 | 201 | PF00026 | 0.463 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5P7 | Leptomonas seymouri | 51% | 100% |
A0A1X0NWT5 | Trypanosomatidae | 31% | 100% |
A0A3R7NTG5 | Trypanosoma rangeli | 31% | 100% |
A0A3S7WW35 | Leishmania donovani | 73% | 100% |
A4HYS4 | Leishmania infantum | 73% | 100% |
E9AUM0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 77% | 99% |
Q4QCW4 | Leishmania major | 75% | 100% |
V5BA94 | Trypanosoma cruzi | 33% | 91% |